SC

Saras Capital

Europe, Kent, United Kingdom, Canterbury

Description

Saras Capital is an a investment firm.

Investor Profile

Saras Capital has made 4 investments, with 2 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (75%)
  • Series C (25%)

Country Focus

  • United Kingdom (50%)
  • United States (25%)
  • France (25%)

Industry Focus

  • Biotechnology
  • Bioinformatics
  • Machine Learning
  • Genetics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Saras Capital frequently co-invest with?

Marshall Wace
Europe, England, United Kingdom, London
Co-Investments: 1
Sahsen Ventures
North America, Washington, United States, Seattle
Co-Investments: 1
UC
Europe, England, United Kingdom, London
Co-Investments: 1
Cancer Research Horizons
Europe, England, United Kingdom, London
Co-Investments: 1
Soleus Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1
S
Europe, England, United Kingdom, London
Co-Investments: 2
Cancer Research Institute
North America, New York, United States, New York
Co-Investments: 1
Bioeconomy Capital
North America, Washington, United States, Seattle
Co-Investments: 1
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 1
DC
Asia, Delhi, India, New Delhi
Co-Investments: 1

Which angels does Saras Capital often collaborate with?

NS
Europe, England, United Kingdom, London
Shared Deals: 1
KM
North America, Kentucky, United States, London
Shared Deals: 1
SB
North America, California, United States, San Francisco
Shared Deals: 1
DH
Europe, England, United Kingdom, London
Shared Deals: 1
AR
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Saras Capital?

Generare

Paris, Ile-de-France, France

Generare is a biotech startup that discovers next-generation medicines and high-value molecules hiding in soil bacteria.

Biotechnology
SeedOct 7, 2024
Amount Raised: $5,487,149
Infinitopes

Oxford, Oxfordshire, United Kingdom

Infinitopes is developer of vaccines for the treatment of cancer.

Biotechnology
SeedApr 30, 2024
Amount Raised: $15,985,813
Parse Biosciences

Seattle, Washington, United States

Parse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.

BioinformaticsBiotechnologyGeneticsLife Science
Series CDec 14, 2023
Amount Raised: $50,000,000
Eden Bio

London, England, United Kingdom

Harnessing nature's potential

BioinformaticsBiotechnologyMachine Learning
SeedNov 14, 2022
Amount Raised: $1,175,206